Winton Matthew 4
4 · CervoMed Inc. · Filed Oct 8, 2025
Insider Transaction Report
Form 4
CervoMed Inc.CRVO
Winton Matthew
Chief Commercial and Business
Transactions
- Award
Stock Option (Right to Buy)
2025-10-06+75,000→ 75,000 totalExercise: $8.62Exp: 2035-10-06→ Common Stock (75,000 underlying)
Footnotes (1)
- [F1]Shares granted as an inducement award material to Dr. Winton's entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4). Award vests in equal monthly installments over thirty-six (36) months on the last day of each month commencing October 31, 2025.